When psoriasis manifests in palmoplantar and intertriginous regions or on the nails, this often poses a therapeutic challenge. Several recently presented analyses on the effects of anti-IL-23p19 antibodies currently approved for psoriasis focused on patient populations with infestation of these difficult-to-treat body regions.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Case report: Acute rheumatic fever
ARF with myocarditis and occlusion of the RCA
- Internal thoracoscopy
Diagnostic indications
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- Follow-up care for head and neck cancer
What is the significance of FDG PET-CT?
- Important basics and studies on cancer and the psyche
Interplay between cancer and mental illness
- Systemic lupus erythematosus
Increased risk of pulmonary manifestations
- Postmenopausal osteoporosis: long-term therapy concepts
Targeted use of antiresorptives and osteoanabolic agents and avoid “rebound” effects
- Late-onset rheumatoid arthritis